RLAY logo

Relay Therapeutics, Inc. (RLAY)

Profile

Full Name

Relay Therapeutics, Inc.

Ticker

NASDAQ: RLAY

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 16, 2020

Indexes

Not included

Website

https://www.relaytx.com

Employees

259

Key Details

Price

$3.69(+3.36%)

Market cap

$636.20M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$10.01M(-60.83% YoY)

Annual EPS

-$2.36(+15.41% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.69
    RLAY price is $3.69

    30-Day Relative Volume

    0.36
    RLAY 30-day relative volume is 0.36

    Price Performance

    Price Most recent change

    +3.36%
    RLAY price was up +3.36% on Aug 28, 2025

    Price YTD change

    -10.44%
    RLAY price is down -10.44% since January 1st

    Price 1-year change

    -45.97%
    RLAY price is down -45.97% year-on-year

    Price 3-year change

    -84.98%
    RLAY price is down -84.98% over the past 3 years

    Price Range

    Price All-time high

    $64.37
    RLAY price is currently -94.27% below its historical high of $64.37

    Price 3-year low

    $1.77
    RLAY price is currently +107.89% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $636.20M
    RLAY market capitalization is $636.20 million

    Market cap 3-year change

    -76.22%
    RLAY market capitalization is down -76.22% over the past 3 years

    Market cap All-time high

    $5.53B
    RLAY market capitalization is currently -88.50% below its historical high of $5.53 billion

    Market cap sector rank

    67.91%
    RLAY market capitalization is higher than 67.91% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +28.77%
    RLAY shares outstanding is up +28.77% year-on-year

    Shares Outstanding 3-Year Change

    +58.32%
    RLAY shares outstanding is up +58.32% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.91
    RLAY beta is 1.91

    200-day SMA

    $3.70
    RLAY price is currently -0.28% below its 200-day simple moving average

    50-day SMA

    $3.51
    RLAY price is currently +4.98% above its 50-day simple moving average

    RSI

    57.43
    RLAY 14-day relative strength index is 57.43

    Volume

    0.36
    RLAY 30-day relative volume is 0.36

    ATR

    $0.19
    RLAY average true range is $0.19

    10-day Historical Volatility

    58.76%
    RLAY 10-day historical volatility is 58.76%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $10.01M
    RLAY annual revenue is $10.01 million

    Revenue Analysts estimate

    $13.49M
    RLAY annual revenue is currently -25.81% lower than the consensus analysts' forecast

    Revenue 1-year change

    -60.83%
    RLAY annual revenue is down -60.83% year-on-year

    Revenue Sector rank

    48.23%
    RLAY annual revenue is higher than 48.23% of companies in Healthcare sector

    EPS

    EPS

    -$2.36
    RLAY annual earnings per share is -$2.36

    EPS Analysts estimate

    -$1.65
    RLAY annual earnings per share is currently +43.39% higher than the consensus analysts' forecast

    EPS 1-year change

    +15.41%
    RLAY annual earnings per share is up +15.41% year-on-year

    EPS Sector rank

    34.33%
    RLAY annual earnings per share is higher than 34.33% of companies in Healthcare sector

    Profit

    Gross profit

    $4.54M
    RLAY annual gross profit is $4.54 million

    Gross margin

    45.40%
    RLAY annual gross profit margin is 45.40%

    Operating profit

    -$385.67M
    RLAY annual operating income is -$385.67 million

    Operating margin

    -3854.04%
    RLAY annual operating profit margin is -3854.04%

    Net income

    -$337.71M
    RLAY annual net profit is -$337.71 million

    Net margin

    -3374.72%
    RLAY annual net profit margin is -3374.72%

    Expenses

    Total expenses

    $395.68M
    RLAY annual total expenses is $395.68 million

    Operating expenses

    $395.68M
    RLAY annual total operating expenses is $395.68 million

    Cost of goods sold

    $5.46M
    RLAY annual cost of goods sold is $5.46 million

    Selling, general & administrative expenses

    $76.59M
    RLAY annual SGA is $76.59 million

    Depreciation and amortization

    $5.46M
    RLAY annual depreciation & amortization is $5.46 million

    Interest expense

    $0.00
    RLAY annual interest expense is $0.00

    Income tax

    $0.00
    RLAY annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$385.67M
    RLAY annual earnings before interest & taxes is -$385.67 million

    EBITDA

    -$380.21M
    RLAY annual EBITDA is -$380.21 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $871.30M
    RLAY annual total assets is $871.30 million

    Non current assets

    $62.09M
    RLAY annual long term assets is $62.09 million

    Current assets

    $809.20M
    RLAY annual total current assets is $809.20 million

    Cash and cash equivalents

    $124.29M
    RLAY annual cash & cash equivalents is $124.29 million

    Accounts receivable

    -
    RLAY annual accounts receivable value is unknown

    Inventory

    $0.00
    RLAY annual inventory is $0.00

    Liabilities

    Total liabilities

    $93.50M
    RLAY annual total liabilities is $93.50 million

    Long term liabilities

    $42.77M
    RLAY annual total long term liabilities is $42.77 million

    Current liabilities

    $50.73M
    RLAY annual total current liabilities is $50.73 million

    Accounts payable

    $14.10M
    RLAY annual accounts payable is $14.10 million

    Debt

    Total debt

    $48.50M
    RLAY annual total debt is $48.50 million

    Total debt 1-year change

    -9.28%
    RLAY annual total debt is down -9.28% year-on-year

    Long term debt

    $42.77M
    RLAY annual long term debt is $42.77 million

    Short term debt

    $5.73M
    RLAY annual short term debt is $5.73 million

    Equity & Capital

    Shareholders equity

    $777.79M
    RLAY annual stockholders equity is $777.79 million

    Book value

    $777.79M
    RLAY annual book value is $777.79 million

    Retained earnings

    -$1.74B
    RLAY annual retained earnings is -$1.74 billion

    Working capital

    $758.48M
    RLAY annual working capital is $758.48 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$249.11M
    RLAY annual cash flow from operations is -$249.11 million

    Cash from operations 1-year change

    +17.05%
    RLAY annual cash flow from operations is up +17.05% year-on-year

    Cash from investing

    -$41.08M
    RLAY annual cash flow from investing activities is -$41.08 million

    Cash from investing 1-year change

    -115.95%
    RLAY annual cash flow from investing activities is down -115.95% year-on-year

    Cash from financing

    $270.15M
    RLAY annual cash flow from financing activities is $270.15 million

    Cash from financing 1-year change

    +677.35%
    RLAY annual cash flow from financing activities is up +677.35% year-on-year

    CAPEX

    CAPEX

    $2.02M
    RLAY annual capital expenditures is $2.02 million

    CAPEX 1-year change

    -51.09%
    RLAY annual capital expenditures is down -51.09% year-on-year

    Free Cash Flow

    Free cash flow

    -$251.13M
    RLAY annual free cash flow is -$251.13 million

    Free cash flow 1-year change

    +17.51%
    RLAY annual free cash flow is up +17.51% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    45.40%
    RLAY annual gross profit margin is 45.40%

    Operating margin

    -3854.04%
    RLAY annual operating profit margin is -3854.04%

    Net margin

    -3374.72%
    RLAY annual net profit margin is -3374.72%

    ROA & ROE

    ROA

    -39.38%
    RLAY annual return on assets is -39.38%

    ROE

    -44.15%
    RLAY annual return on equity is -44.15%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    RLAY price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    RLAY price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.96
    RLAY price to book ratio is 0.96

    PB ratio Sector rank

    34.44%
    RLAY price to book ratio is higher than 34.44% of companies in Healthcare sector

    PS Ratio

    PS ratio

    76.14
    RLAY price to sales ratio is 76.14

    PS ratio Sector rank

    90.18%
    RLAY price to sales ratio is higher than 90.18% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $13.61M
    RLAY enterprise value is $13.61 million

    Enterprise value Sector rank

    25.15%
    RLAY enterprise value is higher than 25.15% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.04
    RLAY EV/EBITDA is -0.04

    EV/EBITDA Sector rank

    62.36%
    RLAY EV/EBITDA is higher than 62.36% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    15.95
    RLAY annual current ratio is 15.95

    Quick ratio

    15.95
    RLAY annual quick ratio is 15.95

    Leverage

    Debt to equity

    0.06
    RLAY annual debt to equity ratio is 0.06

    Interest coverage ratio

    -
    RLAY annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    RLAY piotroski f-score value is unknown

    Altman Z-Score

    0.88
    RLAY altman z-score is 0.88

    Analyst ratings

    Recent major analysts updates

    Aug 8, 25 Raymond James
    Strong Buy
    May 7, 25 Guggenheim
    Buy
    Apr 17, 25 Wells Fargo
    Equal-Weight
    Mar 7, 25 HC Wainwright & Co.
    Buy
    Feb 27, 25 Stifel
    Buy
    Feb 27, 25 Goldman Sachs
    Buy
    Jan 14, 25 HC Wainwright & Co.
    Buy
    Dec 12, 24 JMP Securities
    Market Outperform
    Dec 5, 24 Leerink Partners
    Outperform
    Dec 4, 24 Leerink Partners
    Outperform

    Institutional Ownership

    Screeners with RLAY included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Relay Therapeutics, Inc.?
    • Does Relay Therapeutics, Inc. pay dividends?
    • What sector is Relay Therapeutics, Inc. in?
    • What industry is Relay Therapeutics, Inc. in?
    • What country is Relay Therapeutics, Inc. based in?
    • When did Relay Therapeutics, Inc. go public?
    • Is Relay Therapeutics, Inc. in the S&P 500?
    • Is Relay Therapeutics, Inc. in the NASDAQ 100?
    • Is Relay Therapeutics, Inc. in the Dow Jones?
    • When was Relay Therapeutics, Inc.'s last earnings report?
    • When does Relay Therapeutics, Inc. report earnings?

    What is the ticker symbol for Relay Therapeutics, Inc.?

    The ticker symbol for Relay Therapeutics, Inc. is NASDAQ:RLAY

    Does Relay Therapeutics, Inc. pay dividends?

    No, Relay Therapeutics, Inc. does not pay dividends

    What sector is Relay Therapeutics, Inc. in?

    Relay Therapeutics, Inc. is in the Healthcare sector

    What industry is Relay Therapeutics, Inc. in?

    Relay Therapeutics, Inc. is in the Biotechnology industry

    What country is Relay Therapeutics, Inc. based in?

    Relay Therapeutics, Inc. is headquartered in United States

    When did Relay Therapeutics, Inc. go public?

    Relay Therapeutics, Inc.'s initial public offering (IPO) was on July 16, 2020

    Is Relay Therapeutics, Inc. in the S&P 500?

    No, Relay Therapeutics, Inc. is not included in the S&P 500 index

    Is Relay Therapeutics, Inc. in the NASDAQ 100?

    No, Relay Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Relay Therapeutics, Inc. in the Dow Jones?

    No, Relay Therapeutics, Inc. is not included in the Dow Jones index

    When was Relay Therapeutics, Inc.'s last earnings report?

    Relay Therapeutics, Inc.'s most recent earnings report was on August 7, 2025

    When does Relay Therapeutics, Inc. report earnings?

    The next expected earnings date for Relay Therapeutics, Inc. is November 6, 2025
    On this page